Algert Global LLC cut its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 24.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 28,350 shares of the company's stock after selling 9,178 shares during the period. Algert Global LLC owned 0.05% of Molina Healthcare worth $9,338,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Rothschild Investment LLC raised its position in Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after acquiring an additional 48 shares during the period. Zions Bancorporation National Association UT bought a new position in Molina Healthcare in the first quarter worth approximately $29,000. Deseret Mutual Benefit Administrators raised its position in Molina Healthcare by 60.7% in the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after acquiring an additional 34 shares during the period. Colonial Trust Co SC raised its position in Molina Healthcare by 930.0% in the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after acquiring an additional 93 shares during the period. Finally, Silver Oak Securities Incorporated bought a new position in Molina Healthcare in the first quarter worth approximately $34,000. 98.50% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
MOH has been the topic of several recent research reports. Mizuho decreased their price target on shares of Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a research report on Friday, July 11th. Barclays decreased their price target on shares of Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating on the stock in a research report on Friday, July 25th. Cantor Fitzgerald reissued a "neutral" rating and issued a $210.00 price objective (down from $312.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Robert W. Baird reduced their price objective on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Finally, UBS Group reduced their price objective on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Three analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and an average target price of $242.91.
Read Our Latest Research Report on MOH
Insider Buying and Selling at Molina Healthcare
In related news, COO James Woys bought 10,000 shares of the business's stock in a transaction that occurred on Monday, August 4th. The stock was bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the purchase, the chief operating officer owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director directly owned 17,131 shares of the company's stock, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.26% of the company's stock.
Molina Healthcare Price Performance
Shares of NYSE MOH traded down $0.08 during midday trading on Wednesday, reaching $173.77. The stock had a trading volume of 1,982,962 shares, compared to its average volume of 990,321. The stock has a 50-day moving average of $218.31 and a 200-day moving average of $279.84. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market capitalization of $9.42 billion, a price-to-earnings ratio of 8.56 and a beta of 0.52. Molina Healthcare, Inc has a 12-month low of $151.95 and a 12-month high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business's revenue for the quarter was up 15.7% on a year-over-year basis. During the same period last year, the company earned $5.86 earnings per share. As a group, research analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.